fluoromisonidazole has been researched along with Carcinoma, Oat Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abolmaali, N; Baumann, M; Haase, R; Koch, A; Kotzerke, J; Steinbach, J; Zips, D; Zöphel, K | 1 |
1 other study(ies) available for fluoromisonidazole and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?
Topics: Carcinoma, Small Cell; Female; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2011 |